F-group (family)
107.1.1.9 Cytochrome_CBB3
Ligands and drugs
428
Member domains
301
with ligand contacts (≤ 4 Å)
70.3% of members
228
with DrugDomain annotations
53.3% of members
228
with a DrugBank compound
53.3% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 107.1.1.9 belongs to X-group 107 Cytochrome c-like, which binds 5.5 ligand superclasses per 20 proteins, narrower than 78% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03317 | HEC | Ferroheme C | 185 |
| DB18267 | HEM | Ferroheme | 38 |
| DB03469 | DHE | Heme D | 30 |
| DB09270 | U10 | Ubidecarenone | 4 |
| DB02182 | HEB | Hybrid Between B and C Type Hemes (Protoporphyrin Ixcontaining Fe) | 2 |
| DB00536 | GAI | Guanidine | 1 |
| DB02159 | PGR | (R)-Propylene glycol | 1 |
| DB03309 | NHE | N-cyclohexyltaurine | 1 |
| DB14522 | OH | Hydroxide ion | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| HEC | HEME C | 246 |
| DHE | HEME D | 27 |
| HEM | PROTOPORPHYRIN IX CONTAINING FE | 27 |
| 9YF | (2R)-2-(hexadecanoyloxy)-3-{[(S)-hydroxy{[(1R,2R,3R,4R,5R,6S)-2,3,4,5,6-pentahydroxycyclohexyl]oxy}phosphoryl]oxy}propyl (9S)-9-methyloctadecanoate | 26 |
| MQ9 | MENAQUINONE-9 | 22 |
| IOD | IODIDE ION | 19 |
| CDL | CARDIOLIPIN | 13 |
| U10 | UBIQUINONE-10 | 12 |
| CL | CHLORIDE ION | 10 |
| ZNmetal | ZINC ION | 10 |
| NAmetal | SODIUM ION | 9 |
| FC6 | HEXACYANOFERRATE(3-) | 8 |
| WUO | acyl-phosphatidyl-myo-inositol dimannoside (AcPIM2) | 8 |
| THJ | THIOSULFATE | 6 |
| CDmetal | CADMIUM ION | 3 |
| SO3 | SULFITE ION | 3 |
| 3PE | 1,2-Distearoyl-sn-glycerophosphoethanolamine | 2 |
| CYN | CYANIDE ION | 2 |
| EL6 | [(2S)-2-octadecanoyloxypropyl] octadecanoate | 2 |
| HEB | HEME B/C | 2 |